How the COVID-19 Vaccine for Children Differs From Adults’

 

Key Points:

  • Pfizer recently announced its vaccine for children is more than 90% effective.
  • In vitro diagnostics company Todos Medical announced the launch of their new COVID-19 antibody blood test which will allow unvaccinated and vaccinated people to monitor their immunity levels to the virus.
  • Healthcare professionals weigh the utility of this type of testing given the amount of at-risk people they interact with on a daily basis.

Commentary:

The next step in the fight against the COVID-19 virus has been the approval of the vaccine for children. Most recently, Pfizer announced that the vaccine that was approved for children is 90 percent effective against COVID-19. Now that the children’s vaccine is here, what was its development like compared to the one for adults? Was it easier or harder? We sat down with Gerald Commissiong, CEO of Todos Medical, to get insight into how the industry has approached the task of vaccine research and testing for different demographics.

MarketScale also asked Commissiong about the recent announcement by Todos about the launch of its new COVID-19 antibody blood test, which will allow unvaccinated and vaccinated people to monitor their immunity levels to the virus. What role will such a test play in the larger ecosystem of COVID treatment and mitigation?

Abridged Thoughts:

Initially, it was thought, although it’s not clear why it was thought, that children were not going to be affected by COVID in the same manner that adults were. As a result of that, the primary focus was really adults who were traveling from place to place, country to country who can spread the disease.

And the focus was on being able to really get people back into the office, back to work. What we found, obviously, is that getting back to work requires children to be able to get back to school. And so as we’ve made progress with the initial set of vaccines and really an undefined, unknown dosing schedule that has been figured out through real world decisions by different countries to do different things than the clinical trials, that kind of approach could have been disastrous in children because we know that their immune systems are not anywhere near as developed and that potentially impacting their immune systems in a robust way very early on in development could have significant long term impacts.

Because of that, I think correctly, everyone focused on developing an effective and safe vaccine for adults and then began to think through how to use the data from adults to develop for kids. There was some acceleration in the 12 to 15 year age gap with the Pfizer vaccine. I think that is being rethought extensively now, given some of the data and the younger kids where there is no evidence of myocarditis with a much lower dosing schedule that could potentially be even further reduced with lengthening the spacing between doses.

More Stories Like This:

Should the COVID-19 Vaccine’s Intellectual Property Be Accessible for Everyone?

Is It Time to Revamp the Drug Development Pipeline?

Follow us on social media for the latest updates in B2B!

Image

Latest

How Verizon Business Utilizes UGC for Sales Enablement
How Verizon Business Utilizes UGC for Sales Enablement
April 24, 2025

In this episode of UGC for B2B, host David Dabney welcomes Cesar Teran, Verizon’s Sales Enablement Lead for Channel, to explore how user-generated content (UGC) is transforming training and team engagement at Verizon Business. Cesar shares the journey of introducing UGC into Verizon’s training initiatives, emphasizing the importance of authenticity, collaboration, and celebrating contributions….

Read More
digital freight invoicing
ODeX Is Leading the Charge in Digital Freight Invoicing
April 24, 2025

Global shipping continues to grapple with fragmented billing processes, often delaying cargo movement. According to McKinsey, adopting an electronic bill of lading could save $6.5 billion in direct costs and enable $40 billion in global trade. As vessels carry goods for thousands of shippers per voyage, the administrative burden of managing and reconciling invoices…

Read More
Human Intelligence Movement
Just Thinking… about Reimagining Education for the AI Era with the Human Intelligence Movement
April 24, 2025

As artificial intelligence reshapes education, work, and daily life, educators are grappling with how to prepare students for a future where human skills—not just knowledge—will be paramount. In fact, a growing number of reports highlight that employers increasingly value collaboration, communication, and emotional intelligence over memorized content. Amid this transformation, the Human Intelligence Movement…

Read More
The Value of a Restoration Team with Healthcare Experience
The Value of a Restoration Team with Healthcare Experience
April 24, 2025

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

Read More